🔎 Trials Near Me

Akèy › Twoub depresif majè › Massachusetts

Etid klinik pou Twoub depresif majè nan Massachusetts

45 etid pou Twoub depresif majè ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  • Adams Clinical Boston, Boston
  • Adams Clinical Watertown, Watertown
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

  • Adams Clinical Boston, Boston
  • Adams Clinical Watertown, Watertown
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Oct 1, 2026 · NCT07573176

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  • Adams Clinical LLC, Watertown
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

  • Activmed Practices & Research, Llc - Methuen, Methuen
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

  • Boston Childrens Hospital, Boston
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227454

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Adams Clinical Boston, Boston
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

  • Vanda Investigational Site, Boston
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06830044

The Medically Tailored Groceries and Mental Health Study

  • UMass Chan Medical School, Worcester
  • Community Care Cooperative (C3), Worcester
  • UMass Memorial Health, Worcester
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07779707

Accelerated TMS for Perinatal Depression

  • Brigham and Women's Hospital, Boston
Ap rekrite
Laj 18 a 55 · Fanm · Mizajou Sep 18, 2026 · NCT06968390

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Boston
  • Seaport Investigator Site, Russells Mills
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

  • Adams Clinical, Inc., Watertown
  • Vitalix Clinical, Inc., Worcester
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07284667

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Adams Clinical Boston, Boston
  • Activmed Practices & Research, Llc - Methuen, Methuen
  • Adams Clinical Watertown, Watertown
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

  • Draig Clinical Site, Boston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

  • Draig Clinical Site, Watertown
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969

Home-Based tDCS Treatment Of Major Depressive Disorder

  • Curavit Clinical Research (virtual study site), Boston
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Aug 14, 2026 · NCT06976697

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

  • Athinoula A. Martinos Center for Biomedical Imaging, Charlestown
Ap rekriteFaz 3
Laj 18 a 55 · Tout sèks · Mizajou Aug 13, 2026 · NCT06247839

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

  • Adams Clinical Boston, Boston
  • Adams Clinical Watertown, Boston
  • Vitalix Clinical, Worcester
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 10, 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Adams Clinical Boston, Boston
  • K2 Medical Research - Foxborough, Foxborough
  • Adams Clinical Watertown, Watertown
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Boston Clinical Trials Llc, Boston
  • ELIXIA, Springfield
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • Mayflower Clinical, Russells Mills
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Aug 3, 2026 · NCT06547489

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • Vitalix Clinical, Worcester
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Jul 27, 2026 · NCT07115329

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Boston
  • Neurocrine Clinical Site, Watertown
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

  • Clinical Research Site, Springfield
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 24, 2026 · NCT07484217

Triage Survey for Psychiatry Research Eligibility

  • Adams Clinical, Boston, Boston
  • Adams Clinical, Watertown, Watertown
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT05800925

Neural Correlates of Stress and Perceived Control in Adolescent Depression

  • McLean Hospital, Belmont
Ap rekriteVolontè an sante akeyi
Laj 14 a 18 · Fanm · Mizajou May 19, 2026 · NCT04788524

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation

  • Mclean Hospital, Belmont
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 45 · Tout sèks · Mizajou May 18, 2026 · NCT05232032

Mechanisms Of Orbitofrontal Stimulation in Depression

  • Beth Israel Deaconess Medical Center, Boston
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou May 14, 2026 · NCT07230990

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

  • McLean Hospital, Belmont
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT07560878

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  • Elixia MA, Springfield
  • Adams Clinical, Watertown
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830

Mindfulness-Based fMRI Neurofeedback for Depression

  • Northeastern University, Boston
Ap rekrite
Laj 13 a 18 · Tout sèks · Mizajou Apr 29, 2026 · NCT05617495

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

  • Lindus Health (Virtual Study Site), Boston
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT07280065

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

  • McLean Hospital, Belmont
  • Beth Israel Deaconess Medical Center, Boston
Ap rekriteEtid obsèvasyon
Laj 18 a 40 · Tout sèks · Mizajou Mar 10, 2026 · NCT06740383

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

  • Harvard Medical School, Boston
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Feb 5, 2026 · NCT05573074

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

  • Autobahn Site #137, Boston
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jan 20, 2026 · NCT06633016

Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression

  • Massachusetts General Hospital, Boston
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Dec 12, 2025 · NCT05450432

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Boston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06786624

Stress Dynamics and Familial Risk for Depression in Female Adolescents

  • McLean Hospital, Belmont
Ap rekriteVolontè an sante akeyi
Laj 13 a 15 · Fanm · Mizajou Oct 23, 2025 · NCT06816329

Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

  • McLean Hospital, Belmont
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 45 · Tout sèks · Mizajou Oct 21, 2025 · NCT05630963

Targeting Specific Brain Networks to Treat Specific Symptoms in Depression

  • Massachusetts General Hospital, Boston
Ap rekriteVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 29, 2025 · NCT05523817

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.